Kyi Thar Keywords Quality and Safety of Medicine in Southeast Asia Health wellbeing ADB SECURE Read more about Kyi Thar Dr. Kyi Thar is a medical doctor, public health and pharmacovigilance expert. He has extensive working experience as a consultant for ADB over eight years in various health projects. Previously, he was a Technical Officer for surveillance and epidemiology at the WHO SEARO and the WHO DPR Korea. He was assigned as a Public Health Expert for UNOPS and Technical Director for the Malaria Consortium and Community Partners International. He also served as the Assistant Director for the Ministry of Health in Myanmar.
Abraham Daniel Keywords Quality and Safety of Medicine in Southeast Asia Health wellbeing ADB SECURE Read more about Abraham Daniel Dr. Abraham Daniel is a registered pharmacist with over 15 years of experience spanning community and hospital pharmacy, academic research, pharmaceutical industry roles, and regulatory affairs. He completed his PhD at the University of Tasmania in 2020, focusing on novel therapeutics for progressive vision loss.
Adrien Inoubli Keywords Quality and Safety of Medicine in Southeast Asia Health wellbeing ADB SECURE Read more about Adrien Inoubli Dr. Adrien Inoubli has been Regional Adviser for Medical Products Regulation for 3 years in the WHO Regional Office for South-East Asia. In this position, he has been providing support to member states in strengthening their regulatory systems and has also acted as secretariat for SEARN, the South-East Asia Regulatory Network. Before joining WHO, he worked on regulatory processes, compassionate use, clinical trials, and marketing authorizations for the UK and French medicines agencies. His last position was representing France in the EMA’s pharmacovigilance committee, the PRAC.
SECURE Webinar 19: Enhancing the Quality and Safety of Medicine in Southeast Asia Read more about SECURE Webinar 19: Enhancing the Quality and Safety of Medicine in Southeast Asia COVID-19 posed a major challenge to the global health agenda, with pharmaceutical manufacturers shifting their production and distribution processes to rapidly respond to escalating demands for vaccines and medical products. The pandemic also revitalized the importance of sound pharmacovigilance (PV) systems and national regulatory authorities (NRA) to ensure the safety, quality, and efficacy of vaccines and drugs.
Nilgun Aydogan Keywords Health SECURE vaccine Read more about Nilgun Aydogan Nilgun Aydogan has been working at Gavi, the Vaccine Alliance, since 2007. She is currently the Senior Country Manager. Prior to this role, she worked on Gavi Civil Society Engagement and managed the EURO and PAHO, Gavi Transitioning Countries. Before working in Gavi, Nilgun worked with reputable agencies such as UNICEF, IPPF, the World Bank focusing on maternal and early childhood health and care. Over the years she worked and traveled extensively on projects covering North Africa, Middle East, and Central Asia.
Landscape Assessment and Policy Recommendations: Scaling Nucleic Acid-based Biopharmaceutical Technologies in Asia and the Pacific Read more about Landscape Assessment and Policy Recommendations: Scaling Nucleic Acid-based Biopharmaceutical Technologies in Asia and the Pacific This presentation gives an overview of the landscape assessment and policy recommendations for scaling nucleic acid-based biopharmaceutical technologies in Asia and Pacific region, with a focus on market assessment, technology overview, and capacity building policy briefs for Bangladesh.
Varun Srivastava Keywords Health global health SECURE Read more about Varun Srivastava Varun Srivastava is a Manager at Accenture Development Partnerships' Global Health team, based in Bengaluru, India. With over eight years of experience in the development sector, Varun has deep expertise in public health, including immunization, public health supply chains, surveillance, and health systems strengthening.
Ragini Ahluwalia Keywords Health SECURE vaccine Read more about Ragini Ahluwalia Ragini is the Asia-Pacific Global Health Lead for Accenture Development Partnerships, the social impact and international development arm of Accenture Strategy, and is based in New Delhi, India. She has over 12 years of experience and has participated in and led over 35 projects focused on the domains of life sciences, global health, access and equity, and sustainable development. She specializes in the areas of growth strategy, landscape and opportunity assessment, market sizing, financing evaluation, supply chain assessment, policy reviews, stakeholder engagement, and project management.
Strengthening Domestic Vaccine Development and Manufacturing in Viet Nam as part of Post-COVID-19 Health Security Response Read more about Strengthening Domestic Vaccine Development and Manufacturing in Viet Nam as part of Post-COVID-19 Health Security Response This presentation gives an overview of strengthening domestic vaccine development and manufacturing in Viet Nam as part of the post-COVID-19 health security response.
Aman Singh Keywords Health vaccine SECURE Read more about Aman Singh Amandeep “Aman” Singh is a Technical Officer with the World Health Organization (WHO) in Vanuatu. Before WHO, Aman worked as a Vaccine Financing Specialist (Consultant) with the Asian Development Bank (ADB) in Vietnam and with Gavi as a Technical Advisor on COVID-19 and Pandemic Preparedness in the Policy Design team of the Office of the COVAX Facility. He has also consulted for the UK Foreign, Commonwealth & Development Office (FCDO) Center for Disaster Protection, advising on the global architecture of pandemic policies and financing.